RI
Ridgewood Investments Portfolio holdings
AUM
$231M
1-Year Return
17.35%
This Quarter Return
+4.19%
1 Year Return
+17.35%
3 Year Return
+46.12%
5 Year Return
+86.39%
10 Year Return
–
AUM
$163M
AUM Growth
+$24.9M
(+18%)
Cap. Flow
+$21.1M
Cap. Flow
% of AUM
12.93%
Top 10 Holdings %
Top 10 Hldgs %
23.66%
Holding
829
New
630
Increased
55
Reduced
88
Closed
2
Top Buys
| 1 |
Vanguard Short-Term Treasury ETF
VGSH
|
$3.51M |
| 2 |
RB Global
RBA
|
$573K |
| 3 |
Baxter International
BAX
|
$512K |
| 4 |
International Flavors & Fragrances
IFF
|
$417K |
| 5 |
Amgen
AMGN
|
$416K |
Top Sells
| 1 |
Gilead Sciences
GILD
|
$957K |
| 2 |
Cardinal Health
CAH
|
$805K |
| 3 |
Deere & Co
DE
|
$619K |
| 4 |
Kimberly-Clark
KMB
|
$614K |
| 5 |
Goldman Sachs
GS
|
$511K |
Sector Composition
| 1 | Financials | 23.04% |
| 2 | Healthcare | 10.59% |
| 3 | Technology | 8.9% |
| 4 | Industrials | 7.49% |
| 5 | Consumer Discretionary | 6.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
iShares Russell Mid-Cap ETF
IWR
$44.6B
| $64.9K | 0.04% |
+928
| New | +$64.9K |
|
302
Nasdaq
NDAQ
$53.6B
| $64.6K | 0.04% |
+1,182
| New | +$64.6K |
|
303
NIO
NIO
$13.4B
| $64.4K | 0.04% |
+6,125
| New | +$64.4K |
|
304
Cigna
CI
$81.5B
| $64.2K | 0.04% |
+251
| New | +$64.2K |
|
|
305
Gilead Sciences
GILD
$143B
| $63.8K | 0.04% |
769
-11,532
| -94% | -$957K |
|
306
Toronto Dominion Bank
TD
$127B
| $63K | 0.04% |
+1,052
| New | +$63K |
|
|
ABB
307
DELISTED
ABB Ltd.
ABB
| $62.4K | 0.04% |
+1,821
| New | +$62.4K |
|
308
Hooker Furnishings Corp
HOFT
$117M
| $62.1K | 0.04% |
+3,415
| New | +$62.1K |
|
309
Unity
U
$18.5B
| $61.7K | 0.04% |
+1,902
| New | +$61.7K |
|
310
Equinor
EQNR
$60.1B
| $61.5K | 0.04% |
+2,162
| New | +$61.5K |
|
|
ANSS
311
DELISTED
Ansys
ANSS
| $60.9K | 0.04% |
+183
| New | +$60.9K |
|
312
Trane Technologies
TT
$92.1B
| $59.7K | 0.04% |
+324
| New | +$59.7K |
|
313
Snowflake
SNOW
$75.3B
| $59.5K | 0.04% |
+385
| New | +$59.5K |
|
314
Lockheed Martin
LMT
$108B
| $59.4K | 0.04% |
+126
| New | +$59.4K |
|
315
AstraZeneca
AZN
$253B
| $59.1K | 0.04% |
+852
| New | +$59.1K |
|
316
W.P. Carey
WPC
$14.9B
| $58.1K | 0.04% |
+766
| New | +$58.1K |
|
317
ESAB
ESAB
$7.15B
| $57.9K | 0.04% |
+979
| New | +$57.9K |
|
318
Thermo Fisher Scientific
TMO
$186B
| $57.1K | 0.04% |
+99
| New | +$57.1K |
|
319
Atlassian
TEAM
$45.2B
| $56.5K | 0.03% |
330
| – | – |
|
320
Stellantis
STLA
$26.2B
| $56.4K | 0.03% |
+3,101
| New | +$56.4K |
|
321
Sony
SONY
$165B
| $56.1K | 0.03% |
+3,095
| New | +$56.1K |
|
322
Calavo Growers
CVGW
$485M
| $55.4K | 0.03% |
+1,927
| New | +$55.4K |
|
323
Public Service Enterprise Group
PEG
$40.5B
| $55.2K | 0.03% |
+884
| New | +$55.2K |
|
324
Enbridge
ENB
$105B
| $54.7K | 0.03% |
+1,433
| New | +$54.7K |
|
325
Canadian Pacific Kansas City
CP
$70.3B
| $54.2K | 0.03% |
+705
| New | +$54.2K |
|